On November 1, CMS released the CY 2024 Final Home Health Prospective Payment System Final Rule.  This Rule contains significant changes that expands coverage for lymphedema treatment, including EXTREMIT-EASE.

Lymphedema Coverage

Starting January 1, 2024, ready-to-wear, non-elastic, gradient compression wraps with adjustable straps (like EXTREMIT-EASE!) will be covered for the treatment of lymphedema in the absence of an open ulcer.  When being used to treat lymphedema, three daytime garments or wraps with adjustable straps for each affected limb or area of the body will be allowed, with replacements every 6 months when medically necessary.  Payments for compression bandaging systems under this benefit category will include Phase 1 (acute or decongestive therapy) and Phase 2 (maintenance therapy) lymphedema treatments.

New Coding

With this change, there will be a new set of HCPCS codes to represent compression garments when they are used for lymphedema.  This will result in EXTREMIT-EASE having two different codes, and selection will depend on if it is being used for chronic venous insufficiency (A6545) or if it is being used for lymphedema (A6583).

The code descriptors for A6531, A6532, and A6545 will be modified to clarify their use under the surgical dressing benefit.  The modification will include adding “used as surgical dressing, each” to the end of the current code descriptors.

Lymphedema Versus CVI

This change reinforces the need to differentiate between chronic venous insufficiency and lymphedema.  A basic explanation of the difference is, lymphedema is an abnormal accumulation of lymphatic fluid and chronic venous insufficiency is an abnormal accumulation of blood.  They have different causes and, while there is some overlap in presentation, much of the clinical presentation differs.

The coverage guidelines when using EXTREMIT-EASE for venous leg ulcers / chronic venous insufficiency are not changing.